{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:46:50Z","timestamp":1791982010080,"version":"4.4.0"},"reference-count":48,"publisher":"BMJ","issue":"9","license":[{"start":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T00:00:00Z","timestamp":1790553600000},"content-version":"unspecified","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2025C02075"],"award-info":[{"award-number":["2025C02075"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["2025YFF0500705"],"award-info":[{"award-number":["2025YFF0500705"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82271874"],"award-info":[{"award-number":["82271874"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341205"],"award-info":[{"award-number":["82341205"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82341206"],"award-info":[{"award-number":["82341206"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82425002"],"award-info":[{"award-number":["82425002"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82522004"],"award-info":[{"award-number":["82522004"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82561160165"],"award-info":[{"award-number":["82561160165"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["LR26H080001"],"award-info":[{"award-number":["LR26H080001"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,9,10]]},"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1136\/jitc-2026-015196","type":"journal-article","created":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:05:37Z","timestamp":1790615137000},"page":"e015196","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative clinical outcomes and single-cell profiling of CD19 CAR-T versus blinatumomab for relapsed\/refractory B-ALL"],"prefix":"10.1136","volume":"14","clinical-trial-number":[{"clinical-trial-number":"nct04532268","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Kexin","family":"Wang","sequence":"first","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leijin","family":"Yu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Liang","sequence":"additional","affiliation":[{"name":"Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1123-9407","authenticated-orcid":false,"given":"Fengmei","family":"Song","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Songfu","family":"Jiang","sequence":"additional","affiliation":[{"name":"Wenzhou Medical University, Wenzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Han","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingming","family":"Zhang","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Wen","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lele","family":"Jin","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Xiong","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunfei","family":"Qiu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijun","family":"Xu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoqing","family":"Wei","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0859-7281","authenticated-orcid":false,"given":"Dongrui","family":"Wang","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"},{"name":"Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9564-1852","authenticated-orcid":false,"given":"Yongxian","family":"Hu","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2723-1621","authenticated-orcid":false,"given":"He","family":"Huang","sequence":"additional","affiliation":[{"name":"Bone Marrow Transplantation Center, the First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, China"},{"name":"Institute of Hematology, Zhejiang University, Hangzhou, Zhejiang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,9,28]]},"reference":[{"key":"2026101404551419000_14.9.e015196.1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s00277-023-05241-2","article-title":"Philadelphia-like acute lymphoblastic leukemia: the journey from molecular background to the role of bone marrow transplant-review article","volume":"102","author":"Alghandour","year":"2023","journal-title":"Ann Hematol"},{"key":"2026101404551419000_14.9.e015196.2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/ajh.26853","article-title":"Sequencing antigen-targeting antibodies and cellular therapies in adults with relapsed\/refractory B-cell acute lymphoblastic leukemia","volume":"98","author":"Aldoss","year":"2023","journal-title":"Am J Hematol"},{"key":"2026101404551419000_14.9.e015196.3","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1182\/bloodadvances.2025015936","article-title":"Immunotherapy in the up-front treatment of adult B-cell precursor acute lymphoblastic leukemia: when, how, who?","volume":"10","author":"Datta","year":"2026","journal-title":"Blood Adv"},{"key":"2026101404551419000_14.9.e015196.4","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1182\/bloodadvances.2020003554","article-title":"CAR T cells better than BiTEs","volume":"5","author":"Molina","year":"2021","journal-title":"Blood Adv"},{"key":"2026101404551419000_14.9.e015196.5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2021.0987"},{"key":"2026101404551419000_14.9.e015196.6","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71170-2"},{"key":"2026101404551419000_14.9.e015196.7","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-022-09489-1","article-title":"Humanized CD19 CAR-T cells in relapsed\/refractory B-ALL patients who relapsed after or failed murine CD19 CAR-T therapy","volume":"22","author":"An","year":"2022","journal-title":"BMC Cancer"},{"key":"2026101404551419000_14.9.e015196.8","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-005701","article-title":"Safety and efficacy of autologous and allogeneic humanized CD19-targeted CAR-T cell therapy for patients with relapsed\/refractory B-ALL","volume":"11","author":"Song","year":"2023","journal-title":"J Immunother Cancer"},{"key":"2026101404551419000_14.9.e015196.9","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.758"},{"key":"2026101404551419000_14.9.e015196.10","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.20908"},{"key":"2026101404551419000_14.9.e015196.11","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/bloodadvances.2025018168","article-title":"FLT3-directed BiTE molecules vs CAR T cells in AML: costimulatory signals mitigate T-cell exhaustion","volume":"10","author":"Rohrbacher","year":"2026","journal-title":"Blood Adv"},{"key":"2026101404551419000_14.9.e015196.12","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-2760"},{"key":"2026101404551419000_14.9.e015196.13","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-025-08713-9"},{"key":"2026101404551419000_14.9.e015196.14","doi-asserted-by":"publisher","DOI":"10.1038\/cdd.2011.5"},{"key":"2026101404551419000_14.9.e015196.15","doi-asserted-by":"publisher","DOI":"10.1038\/ncb0502-e131"},{"key":"2026101404551419000_14.9.e015196.16","doi-asserted-by":"publisher","DOI":"10.1038\/msb.2013.25"},{"key":"2026101404551419000_14.9.e015196.17","doi-asserted-by":"publisher","DOI":"10.1056\/nejmra1706169"},{"key":"2026101404551419000_14.9.e015196.18","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-18-0297"},{"key":"2026101404551419000_14.9.e015196.19","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-010064","article-title":"Comparison of CAR T-cell and bispecific antibody as third-line or later-line treatments for multiple myeloma: a meta-analysis","volume":"12","author":"Liang","year":"2024","journal-title":"J Immunother Cancer"},{"key":"2026101404551419000_14.9.e015196.20","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.3324\/haematol.2024.287215","article-title":"Teclistamab versus B-cell maturation antigen-targeting chimeric antigen receptor T-cell therapy in multiple myeloma: a comparative effectiveness analysis","volume":"110","author":"Song","year":"2025","journal-title":"Haematologica"},{"key":"2026101404551419000_14.9.e015196.21","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1182\/bloodadvances.2020004045","article-title":"Indirect comparison of tisagenlecleucel and blinatumomab in pediatric relapsed\/refractory acute lymphoblastic leukemia","volume":"5","author":"Verneris","year":"2021","journal-title":"Blood Adv"},{"key":"2026101404551419000_14.9.e015196.22","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023023419"},{"key":"2026101404551419000_14.9.e015196.23","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cncr.33967","article-title":"Extramedullary disease relapse and progression after blinatumomab therapy for treatment of acute lymphoblastic leukemia","volume":"128","author":"Aldoss","year":"2022","journal-title":"Cancer"},{"key":"2026101404551419000_14.9.e015196.24","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-08-798322"},{"key":"2026101404551419000_14.9.e015196.25","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1609783"},{"key":"2026101404551419000_14.9.e015196.26","doi-asserted-by":"publisher","DOI":"10.1158\/2643-3230.BCD-21-0038"},{"key":"2026101404551419000_14.9.e015196.27","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709919"},{"key":"2026101404551419000_14.9.e015196.28","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1182\/blood.2019001463","article-title":"Preemptive mitigation of CD19 CAR T-cell cytokine release syndrome without attenuation of antileukemic efficacy","volume":"134","author":"Gardner","year":"2019","journal-title":"Blood"},{"key":"2026101404551419000_14.9.e015196.29","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1804980"},{"key":"2026101404551419000_14.9.e015196.30","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1709866"},{"key":"2026101404551419000_14.9.e015196.31","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1707447"},{"key":"2026101404551419000_14.9.e015196.32","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1182\/bloodadvances.2019001381","article-title":"Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab","volume":"4","author":"Badar","year":"2020","journal-title":"Blood Adv"},{"key":"2026101404551419000_14.9.e015196.33","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1002\/ajh.70057","article-title":"The Impact of Cytoreduction on Blinatumomab Outcomes for Relapsed or Refractory B-ALL With High Disease Burden","volume":"100","author":"Tinajero","year":"2025","journal-title":"Am J Hematol"},{"key":"2026101404551419000_14.9.e015196.34","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.34667"},{"key":"2026101404551419000_14.9.e015196.35","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-090222-110914"},{"key":"2026101404551419000_14.9.e015196.36","doi-asserted-by":"crossref","first-page":"3416","DOI":"10.1016\/j.apsb.2024.04.022","article-title":"Unlocking T cell exhaustion: Insights and implications for CAR-T cell therapy","volume":"14","author":"Xiong","year":"2024","journal-title":"Acta Pharm Sin B"},{"key":"2026101404551419000_14.9.e015196.37","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-019-1805-z"},{"key":"2026101404551419000_14.9.e015196.38","doi-asserted-by":"crossref","DOI":"10.1186\/s40364-022-00434-9","article-title":"Strategies to enhance CAR-T persistence","volume":"10","author":"Liu","year":"2022","journal-title":"Biomark Res"},{"key":"2026101404551419000_14.9.e015196.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-020-0956-8"},{"key":"2026101404551419000_14.9.e015196.40","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-019-0051-2"},{"key":"2026101404551419000_14.9.e015196.41","doi-asserted-by":"crossref","first-page":"3064","DOI":"10.1038\/s41375-020-0760-x","article-title":"Serial evaluation of CD19 surface expression in pediatric B-cell malignancies following CD19-targeted therapy","volume":"34","author":"Libert","year":"2020","journal-title":"Leukemia"},{"key":"2026101404551419000_14.9.e015196.42","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000692"},{"key":"2026101404551419000_14.9.e015196.43","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1158\/1078-0432.CCR-23-3841","article-title":"Mesothelin CAR T Cells Secreting Anti-FAP\/Anti-CD3 Molecules Efficiently Target Pancreatic Adenocarcinoma and its Stroma","volume":"30","author":"Wehrli","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2026101404551419000_14.9.e015196.44","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2019.01.008"},{"key":"2026101404551419000_14.9.e015196.45","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-009048","article-title":"CD22 CAR-T cells secreting CD19 T-cell engagers for improved control of B-cell acute lymphoblastic leukemia progression","volume":"13","author":"Arroyo-R\u00f3denas","year":"2025","journal-title":"J Immunother Cancer"},{"key":"2026101404551419000_14.9.e015196.46","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1182\/blood.2023023210","article-title":"CD70 CAR T cells secreting an anti-CD33\/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML","volume":"145","author":"Silva","year":"2025","journal-title":"Blood"},{"key":"2026101404551419000_14.9.e015196.47","doi-asserted-by":"publisher","DOI":"10.1002\/jcph.1006"},{"key":"2026101404551419000_14.9.e015196.48","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/bcp.13864","article-title":"Exposure-response analysis of blinatumomab in patients with relapsed\/refractory acute lymphoblastic leukaemia and comparison with standard of care chemotherapy","volume":"85","author":"Kuchimanchi","year":"2019","journal-title":"Br J Clin Pharmacol"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2026-015196","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:55:24Z","timestamp":1791978924000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2026-015196"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":48,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2026,9,28]]},"published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1136\/jitc-2026-015196"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2026-015196","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]}}}